FDA 483 - United Laboratories Manufacturing, LLC - August 15, 2025

United Laboratories Manufacturing, LLC was inspected and found to have severe deficiencies across its quality systems. Key issues include a fundamental breakdown in the Quality Unit's oversight, distribution of out-of-specification drug products, inadequate deviation and OOS investigations, and insufficient employee training. These failures compromise product quality, regulatory compliance, and potentially consumer health.